Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 2Vascular Malformations 1Triple Negative Breast Neoplasms 1Peutz-Jeghers Syndrome 1Perivascular Epithelioid Cell Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Malignant Solid Tumors 1Lymphangioma 1Lymphangioleiomyomatosis 1Leiomyoma 1Kaposiform Hemangioendothelioma 1Hereditary Sensory and Autonomic Neuropathies 1Hematologic Neoplasms 1Hemangioendothelioma 1Graft vs Host Disease 1Epilepsy 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Advanced Solid Tumors 1

Interventions

Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Kaposiform Hemangioendothelioma × Sirolimus × Clear all
NCT05324384 2024-01-24

Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma

West China Hospital

Phase 2 Unknown
30 enrolled

Kaposiform Hemangioendothelioma, Hemangioendothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡